Recipients are medical groups.

Collaborative organizations will be able to network with peers frequently, take part in bi-monthly meeting calls on relevant project topics, attend two in-person meetings, and have timely access to skillfully developed. The Learning Collaborative commenced in November 2010 and continues through November 2011. The Chronic Obstructive Pulmonary Disease GUIDELINES Learning Collaborative is an educational service backed by Boehringer Ingelheim Pharmaceuticals, Inc.. AMGA, AMGF announce grantees in COPD Best Practices Learning Collaborative The American Medical Group Association and the American Medical Group Base today announced recipients of grants for quality improvement initiatives focusing on care management for patients with Chronic Obstructive Pulmonary Disease .But this is one part of learning more about not only the slowing of ageing, but also the reversal.

Agios Pharmaceuticals presents data on cancer-associated IDH1 mutations at 101st AACR meeting Agios Pharmaceuticals, a biopharmaceutical company centered on discovering and developing novel drugs in neuro-scientific cancer rate of metabolism, today announced multiple presentations at the American Association for Cancers Study 101st Annual Meeting that highlight malignancy metabolism as a procedure for identify new methods to treat cancer, starting the potential for a new class of cancer medicines targeting metabolic enzymes. This breakthrough discovery implies that the mutated type of IDH1 generates a metabolite, 2-hydroxyglutarate , which might contribute to the formation and onco-malignant progression of gliomas, the most common kind of mind cancers.